Prediction: 3 Stocks That Will Be Worth More Than Palantir 5 Years From Now
Palantir's stock price has risen much faster than its business has grown.
ASML, Salesforce, and IBM all have strong investments in AI.
10 stocks we like better than Palantir Technologies ›
Palantir Technologies (NASDAQ: PLTR) experienced a significant rise over the past few years and is now the 24th largest company by market capitalization globally. However, through a combination of factors, I think there could be multiple stocks that pass Palantir over the coming years.
Three that I think have that chance are ASML Holding (NASDAQ: ASML), International Business Machines (NYSE: IBM), and Salesforce (NYSE: CRM), but this list could grow if the market comes to its senses regarding Palantir's stock.
Palantir's stock appears to be significantly overvalued
Palantir has been on an absolute tear since the start of 2024, rising nearly 800%. However, its revenue only grew 39% year over year in the first quarter, indicating a significant disparity between stock price appreciation and actual business growth.
This shows up in the stock's valuation, which trades for 113 times sales and 244 times forward earnings.
PLTR PS Ratio data by YCharts; PS = price to sales, PE = price to earnings.
Very few companies ever reach this valuation for good reason: It's nearly impossible to live up to expectations. If we use a five-year timeline to examine Palantir's stock, let's make the following assumptions:
Revenue growth of 40%.
Profit margin reaches 30%.
Share count remains flat.
Those are three incredibly bullish assumptions -- the company hasn't achieved 40% year-over-year growth in recent quarters and would have to sustain that for five years. Also, a 30% profit margin would place it among the best software companies, and its current 18% margin is still a considerable distance from that level.
Lastly, management is notorious for issuing a large number of shares to employees, and its share count has increased by 7.3% since the start of 2024, indicating significant dilution.
Regardless, if these heady assumptions could come true, Palantir would generate $16.8 billion in revenue and $5 billion in profits. That's huge growth from today's $3.1 billion in revenue, but it would still value the company at 67 times hypothetical 2030 earnings.
A 67 multiple for forward earnings makes for a very expensive stock, and Nvidia, which is consistently growing faster than Palantir, has only a 38 forward earnings multiple right now.
I think this is a fairly clear-cut case that Palantir is drastically overvalued at today's levels. Even with the most bullish assumptions, Palantir's stock would still appear overvalued five years from now, even if the company achieves incredible growth figures.
As a result, I believe the stock is ripe for a decline, and there are many other stocks (beyond the ones I mentioned) that could surpass Palantir.
This trio has a strong outlook and significantly cheaper prices
ASML is only slightly behind Palantir's $362 billion market cap, with a valuation of $292 billion at the time of this writing. It is a key provider of machinery in chip manufacturing, and it holds a technological monopoly with its extreme ultraviolet (EUV) machines.
As more chip fabrication facilities emerge to support the huge AI demand, the company will experience strong growth, which management has told investors to expect in 2026. As a result, I think ASML could easily surpass Palantir.
IBM is a legacy computing business that's working to make the pivot into AI and quantum computing, which is forecast to see commercial adoption around 2030. If it becomes the go-to for this technology, the stock could be ripe for huge upside from its current $266 billion valuation.
Lastly, Salesforce dominates in customer relationship management software. It's also working to integrate AI into its product and maximize its profitability. Compared to many stocks on the market, it is relatively cheap and is valued at a lower level than the S&P 500, which trades for 23.7 times forward earnings.
IBM PE Ratio (Forward) data by YCharts.
As a final note, all three of these stocks trade for far less than Palantir's hypothetical 2030 valuation, which should be a sign for investors that the stock is unsustainably expensive. There is a near-endless list of stocks that appear to be better investments, and these three are among them.
Should you invest $1,000 in Palantir Technologies right now?
Before you buy stock in Palantir Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!*
Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 15, 2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
19 minutes ago
- Globe and Mail
Class Action Lawsuit Filed: Fortrea Holdings Inc. (FTRE) - Join by August 1, 2025 - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - July 21, 2025) - If you suffered a loss on your Fortrea Holdings Inc. (NASDAQ: FTRE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Fortrea Holdings Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between July 3, 2023 and February 28, 2025. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Fortrea overestimated the amount of revenue the long-term projects in its portfolio, the Pre-Spin Projects, were likely to contribute to the Company's 2025 earnings; (ii) Fortrea overstated the cost savings it would likely achieve by exiting the transition services agreements; (iii) as a result, the Company's previously announced EBITDA targets for 2025 were inflated; (iv) accordingly, the viability of the Company's post-spin-off business model, as well as its business and/or financial prospects, were overstated; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times. WHAT'S NEXT? If you suffered a loss in Fortrea Holdings Inc. stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
Globe and Mail
19 minutes ago
- Globe and Mail
ITOS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iTeos Therapeutics, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of iTeos Therapeutics, Inc. (NASDAQ: ITOS) to Concentra Biosciences, LLC is fair to iTeos shareholders. Under the terms of the proposed transaction, Concentra will acquire iTeos for $10.047 in cash per share, plus one non-transferable contingent value right, representing the right to receive: (i) 100% of the closing net cash of iTeos in excess of $475 million; and (ii) 80% of any net proceeds received from any disposition of certain of iTeos' product candidates that occurs within six months following the closing. Halper Sadeh encourages iTeos shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@ or zhalper@ The investigation concerns whether iTeos and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for iTeos shareholders; (2) determine whether Concentra is underpaying for iTeos; and (3) disclose all material information necessary for iTeos shareholders to adequately assess and value the merger consideration. On behalf of iTeos shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
CTV News
19 minutes ago
- CTV News
Wall Street drifts around its records ahead of a big week for profit reports
NEW YORK — U.S. stocks are drifting on Monday ahead of a week full of profit updates from big U.S. companies, which Wall Street expects to keep growing despite pressure from U.S. President Donald Trump's tariffs. The S&P 500 was 0.3 per cent higher in early trading and just above its all-time high set on Thursday. The Dow Jones Industrial Average was up 52 points, or 0.1 per cent, as of 9:35 a.m. Eastern time, and the Nasdaq composite was adding 0.4 per cent to its own record. Verizon Communications helped lead the way and rose three per cent. The telecom reported a stronger profit for the latest quarter than analysts expected, along with higher revenue than forecast. Following the strong performance, Verizon raised its forecasts for profit and other financial measures for the full year. It helped offset a 0.4 per cent dip for Microsoft, which issued an emergency fix to close off a vulnerability in its SharePoint software that hackers have exploited to carry out widespread attacks on businesses and at least some federal agencies. Block, Jack Dorsey's company behind Square, Cash App and other tech brands, jumped 6.7 per cent in its first trading after learning it will join the widely followed and imitated S&P 500 index before trading begins on Wednesday. It will replace Hess, which Chevron bought. Cleveland-Cliffs rallied 6.8 per cent after the steel producer reported a smaller loss for the spring than analysts expected. It shipped a record 4.3 million net tons of steel during the quarter, and CEO Lourenco Goncalves said the company has begun to see 'the positive impact that tariffs have on domestic manufacturing' and other things. It's a major supplier to the auto industry, and Trump's tariffs steer companies hoping to sell cars in the United States toward steel made in the country. Other companies, though, are navigating the downsides and complications of tariffs, which raise prices on all kinds of things imported to the United States. That includes General Motors, which will report its latest profit results later this week, along with such market heavyweights as Alphabet, Coca-Cola and Tesla. Many of Trump's stiff proposed tariffs are currently on pause after Trump extended the deadline for talks with other countries in order to give more time to reach potential trade deals that could lower the tax rates. The next big deadline, at least for now, is Aug. 1. It's still early days in this earnings reporting season, but most big U.S. companies have been topping analysts' expectations, as is usually the case. Some encouraging undertones may also be emerging. An upward inflection in demand for travel that United Airlines said it's seen recently, combined with some better-than-expected data on U.S. retail sales, may indicate that U.S. consumers remain in decent health and could continue to support the economy, Bank of America strategist Savita Subramanian said in a BofA Global Research report. In the bond market, Treasury yields eased. The yield on the 10-year Treasury fell to 4.38 per cent from 4.44 per cent late Friday. In stock markets abroad, indexes slipped across much of Europe after finishing modestly higher in much of Asia. Markets were closed for a holiday in Japan, where the ruling Liberal Democrats have lost their coalition majorities in both houses of parliament for the first time since 1955 following Sunday's upper house election and the loss of their lower house majority in October. A grim Prime Minister Shigeru Ishiba has vowed to stay on after the drubbing by voters frustrated over rising prices and political instability. Analysts said they expect his weakened government to crank up spending, adding to Japan's huge debt burden. ___ AP business writers Matt Ott and Elaine Kurtenbach contributed. By Stan Choe
